Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TX77L | — |
Infanrix given to a patient, instead of Boostrix; Infanrix given to a 20-year-old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 20-year-old female patient who received DTPa (Infanrix) (batch number TX77L, expiry date 01-DEC-2025) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 21-AUG-2025, the patient received Infanrix. The patient did not receive Boostrix. On 21-AUG-2025, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: Infanrix given to a patient, instead of Boostrix) and inappropriate age at vaccine administration (Verbatim: Infanrix given to a 20-year-old patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2025 Nurse reported that Infanrix was given to a patient, instead of Boostrix. The vaccine administration facility was the same as primary reporter.